Globavend is trading $1.08, up 11.95% in pre-market on October 19, 2026, with no fresh company-specific catalyst identified.
- U.S. indices were higher, offering a possible broader-market backdrop; no direct link to Globavendβs move is established.
- The price compares with the October 16 close of $0.96.
- Its ThinkEquity presentation was announced October 13 and held October 15, making it prior context, not a new overnight announcement. Pre-market volume was not provided, limiting assessment.